The week of 2026-09-14, 19 holders filed a new Schedule 13D and 43 a new Schedule 13G reporting 5% or more of a company, and 0 13D filings stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-09-15 | General Steel Holdings Inc | Alternative Liquidity Index LP | 83% | SCHEDULE 13D |
| 2026-09-16 | Stewards, Inc. | Glen Anthony Whitefoord Steward | 35.9% | SCHEDULE 13D |
| 2026-09-15 | JATT II Acquisition Corp. | JATT Ventures II L.P. | 23.1% | SCHEDULE 13D |
| 2026-09-17 | 111, Inc. | Gang Yu | 21.4% | SCHEDULE 13D |
| 2026-09-16 | Stewards, Inc. | Vincent C Napolitano | 19.2% | SCHEDULE 13D |
| 2026-09-16 | Stewards, Inc. | Charles Robert Abele | 17.2% | SCHEDULE 13D |
| 2026-09-18 | Rainmaker Worldwide Inc. | Michael John O'Connor | 16% | SCHEDULE 13D |
| 2026-09-18 | TROOPS, Inc. | Jmd Corporate Services Limited | 14.7% | SCHEDULE 13D |
| 2026-09-18 | New Fortress Energy Inc. | Strategic Value Partners, LLC | 14.7% | SCHEDULE 13D |
| 2026-09-15 | Korsana Biosciences, Inc. | Venrock Healthcare Capital Partners III, L.P. | 9.9% | SCHEDULE 13D |
| 2026-09-16 | Stewards, Inc. | Shaun Anthony Quin | 9.6% | SCHEDULE 13D |
| 2026-09-17 | Vulcan Infrastructure And Power Inc. | Rogers George Ted III | 8.5% | SCHEDULE 13D |
| 2026-09-16 | Vulcan Infrastructure And Power Inc. | Mig Ref Ii Infr, LLC | 8.23% | SCHEDULE 13D |
| 2026-09-17 | FibroBiologics, Inc. | Hamid Khoja | 7.5% | SCHEDULE 13D |
| 2026-09-15 | XCF Global, Inc. | GL Part SPV II, LLC | 6.7% | SCHEDULE 13D |
| 2026-09-16 | Vail Resorts Inc | Oasis Management Co Ltd. | 6.2% | SCHEDULE 13D |
| 2026-09-17 | OraSure Technologies, Inc. | Islet Management, LP | 5.7% | SCHEDULE 13D |
| 2026-09-14 | Medicus Pharma Ltd. | Bokhari, Raza | 5.3% | SCHEDULE 13D |
| 2026-09-16 | Dynatrace, Inc. | Pictet Asset Management Sa | 5% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-09-15 | AEVEX Corp. | Razor's Edge Fund III, LP | 18.4% | SCHEDULE 13G |
| 2026-09-14 | SunPower Inc. | The Vallejo Ventures Trust U/T/A 2/12/96 | 14% | SCHEDULE 13G |
| 2026-09-18 | Direxion Shares ETF Trust | Upender V. Rao | 13.8% | SCHEDULE 13G |
| 2026-09-14 | Guardian Metal Resources PLC | Duquesne Family Office LLC | 12.7% | SCHEDULE 13G |
| 2026-09-16 | Magnolia Oil & Gas Corp | WildFire Energy I LLC | 11.96% | SCHEDULE 13G |
| 2026-09-15 | Private Bancorp of America, Inc. | Selwyn Isakow | 10.3% | SCHEDULE 13G |
| 2026-09-15 | GT Biopharma, Inc. | RainForest Partners, LLC | 9.99% | SCHEDULE 13G |
| 2026-09-15 | PMV Pharmaceuticals, Inc. | Srinivas Akkaraju | 9.9% | SCHEDULE 13G |
| 2026-09-14 | Safe Pro Group Inc. | Phillip Frost, M.D. | 9.82% | SCHEDULE 13G |
| 2026-09-18 | Creatd, Inc. | Castaldo Gregory | 9.61% | SCHEDULE 13G |
| 2026-09-18 | Creatd, Inc. | Joseph Reda | 9.45% | SCHEDULE 13G |
| 2026-09-18 | Liberty Live Holdings, Inc. | Linonia Partners Fund LP | 9.3% | SCHEDULE 13G |
| 2026-09-18 | Liberty Live Holdings, Inc. | Linonia Partners Fund LP | 9.2% | SCHEDULE 13G |
| 2026-09-16 | Nova Ltd. | Phoenix Financial Ltd. | 8.64% | SCHEDULE 13G |
| 2026-09-18 | Alector, Inc. | Bvf Partners L P | 8.4% | SCHEDULE 13G |
| 2026-09-14 | Blue Laser Fusion, Inc. | Mirai Creation Fund III | 8.32% | SCHEDULE 13G |
| 2026-09-17 | Marine Petroleum Trust | Ottie K. Paslay | 8.1% | SCHEDULE 13G |
| 2026-09-18 | Microvision, Inc. | Gnauck Johannes | 7.9% | SCHEDULE 13G |
| 2026-09-17 | QHSLab, Inc. | Jeremy L. Smollar Irrevocable Trust dtd 2/13/2023 | 7.4% | SCHEDULE 13G |
| 2026-09-14 | Andretti Acquisition Corp. II | Linden Advisors LP | 7.3% | SCHEDULE 13G |
| 2026-09-17 | Yarrow Bioscience, Inc. | Raymond Debbane | 7.2% | SCHEDULE 13G |
| 2026-09-18 | Korsana Biosciences, Inc. | General Atlantic, L.P. | 6.8% | SCHEDULE 13G |
| 2026-09-18 | Creatd, Inc. | SEG Opportunity Fund, LLC | 6.53% | SCHEDULE 13G |
| 2026-09-14 | SunPower Inc. | Crosslink Capital, Inc. | 6.2% | SCHEDULE 13G |
| 2026-09-16 | Korsana Biosciences, Inc. | Wellington Biomedical Innovation Master Investors (Cayman) II, L.P. | 6.1% | SCHEDULE 13G |
| 2026-09-17 | Tyra Biosciences, Inc. | Paradigm BioCapital Advisors LP | 5.8% | SCHEDULE 13G |
| 2026-09-17 | Kiora Pharmaceuticals, Inc. | Baselake Partners, LP | 5.8% | SCHEDULE 13G |
| 2026-09-16 | Dominari Holdings Inc. | Donald J. Trump Jr. | 5.77% | SCHEDULE 13G |
| 2026-09-16 | Dominari Holdings Inc. | Eric Trump | 5.77% | SCHEDULE 13G |
| 2026-09-15 | Hepion Pharmaceuticals, Inc. | Kenneth Rickel | 5.7% | SCHEDULE 13G |
| 2026-09-16 | Redwood Trust Inc | Bay Pond Partners, L.P. | 5.7% | SCHEDULE 13G |
| 2026-09-16 | Nephros, Inc. | Charles E. Davidson | 5.68% | SCHEDULE 13G |
| 2026-09-17 | Bright Horizons Family Solutions Inc. | Abrams Bison Investments, L.L.C. | 5.6% | SCHEDULE 13G |
| 2026-09-18 | Lincoln International, Inc. | Millennium Management LLC | 5.6% | SCHEDULE 13G |
| 2026-09-17 | Hyperscale Data, Inc. | SJC Lending, LLC | 5.5% | SCHEDULE 13G |
| 2026-09-15 | Venture Global, Inc. | D. E. Shaw & Co., L.P. | 5.4% | SCHEDULE 13G |
| 2026-09-16 | Regal Rexnord Corp | Viking Global Investors LP | 5.4% | SCHEDULE 13G |
| 2026-09-17 | Clipper Realty Inc. | Marc Bistricer | 5.4% | SCHEDULE 13G |
| 2026-09-16 | Ormat Technologies, Inc. | Phoenix Financial Ltd. | 5.31% | SCHEDULE 13G |
| 2026-09-18 | Maison Solutions Inc. | Jane Street Group, LLC | 5.3% | SCHEDULE 13G |
| 2026-09-14 | Capricor Therapeutics, Inc. | Millennium Management LLC | 5.1% | SCHEDULE 13G |
| 2026-09-17 | Fossil Group, Inc. | Kanen Wealth Management LLC | 5.1% | SCHEDULE 13G |
| 2026-09-17 | Fossil Group, Inc. | Kanen Wealth Management LLC | 5.1% | SCHEDULE 13G |
Stated intent
No 13D this week stated an intent to influence the company.
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.